Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian Patients

Abstract

BackgroundThe emergence and transmission of HIV-1 drug resistance (HIVDR) has raised concerns after rapid global antiretroviral therapy (ART) scale-up. There are limited data on the epidemiology of primary HIVDR in resource-limited settings in Asia. We aimed to determine the prevalence and compare the distribution of HIVDR in a cohort of ART-naïve Asian patients with recent and chronic HIV-1 infection.MethodsMulticenter prospective study was conducted in ART-naïve patients between 2007 and 2010. Resistance-associated mutations (RAMs) were assessed using the World Health Organization 2009 list for surveillance of primary HIVDR.ResultsA total of 458 patients with recent and 1,340 patients with chronic HIV-1 infection were included in the analysis. The overall prevalence of primary HIVDR was 4.6%. Recently infected patients had a higher prevalence of primary HIVDR (6.1% vs. 4.0%, p = 0.065) and frequencies of RAMs to protease inhibitors (PIs; 3.9% vs. 1.0%, p<0.001). Among those with recent infection, the most common RAMs to nucleoside reverse transcriptase inhibitors (NRTIs) were M184I/V and T215D/E/F/I/S/Y (1.1%), to non-NRTIs was Y181C (1.3%), and to PIs was M46I (1.5%). Of patients with chronic infection, T215D/E/F/I/S/Y (0.8%; NRTI), Y181C (0.5%; non-NRTI), and M46I (0.4%; PI) were the most common RAMs. K70R (p = 0.016) and M46I (p = 0.026) were found more frequently among recently infected patients. In multivariate logistic regression analysis in patients with chronic infection, heterosexual contact as a risk factor for HIV-1 infection was less likely to be associated with primary HIVDR compared to other risk categories (odds ratio 0.34, 95% confidence interval 0.20–0.59, p<0.001).ConclusionsThe prevalence of primary HIVDR was higher among patients with recent than chronic HIV-1 infection in our cohort, but of borderline statistical significance. Chronically infected patients with non-heterosexual risks for HIV were more likely to have primary HIVDR.

An Alarmingly High Proportion of HIV-1 Isolates Carrying Mutations Corresponding to Resistance to Antiretroviral Drugs among HIV-Positive High-Risk Groups in Central Vietnam: a Substudy of the National Sentinel Survey

“…Higher DRM rates, 9.2 and 14.2 , were observed among ART-naïve MSM in Thailand and China, respectively (21,22). Several reports indicate that MSM and IDU groups have higher rates of DRMs than other groups do (20,22,23).…”

Transmitted drug resistance in recently infected HIV-positive Individuals from four urban locations across Asia (2007–2010) – TASER-S

“…Treatment-naïve, recently HIV-infected patients were recruited into the TREAT Asia Studies to Evaluate Resistance – Surveillance Study (TASER-S) between 2007-2010 [ 7 ] from 5 participating sites: 2 from Hong Kong SAR, China; 1 from Bangkok, Thailand; 1 from Chiang Mai, Thailand; and 1 from Manila, Philippines. Patients were included in TASER-S according to the following inclusion criteria:…”

Challenges and potential barriers to the uptake of antiretroviral-based prevention in Asia and the Pacific region

“…Individuals who reported nonheterosexual contact as a risk factor were more likely to have drug resistance. 91 Drug resistance peaks at some intermediate level of compliance or effectiveness. 92 One modelling study predicts that even with a very high usage of ART (a median of 70% of HIV-infected men receiving therapy), transmitted resistance would initially increase but would then fairly quickly stabilise at a relatively low level (between 6% and 21%).…”